CAS: 22161-81-5; (S)-2-(3-Benzoylphenyl)Propanoic Acid

该化合物是属于丙烯丙酸类的非类物质抗炎药物,是Ketoprofen的药用活性对应剂,属于丙烯丙烯酸类.作为脱氧形式,它比种族混合物具有更高的威力,增加了环氧酶抑制的选择性,从而改善了低剂量的抗炎,止痛剂和抗过激效应,降低了不良胃肠道和肾脏效应的风险.S-(+)-Ketoprofen因其高抗蛋白纯度和精美化的药用皮肤特征,在药物研发中被广泛使用.它的天体特性使得它对于研究定型选择性药物代谢和在临床应用中优化治疗效果很有价值.

结构式图片

欧盟法规

REACH注册C&L通报REACH预注册

上下游产品

CAS号60658-04-0 2-(3-苯甲酰基苯基)丙酸乙酯 | CAS号22071-15-4 酮洛芬 | CAS号59512-44-6 3-benzoyl-α-met... | CAS号57872-48-7 methyl α-(m-ben... | CAS号114315-58-1 ketoprofen 2-ch... | CAS号39172-32-2 2-(3-溴苯基)-2-甲基-... | CAS号17983-62-9 1-[3-(trimethyl... | CAS号2142-63-4 3-溴代苯乙酮 | CAS号66067-43-4 3-乙基二苯甲酮

合成工艺路线路线简述

    3-(3-Benzoyl-Phenyl)-2S,3R-Dimethyl-Oxirane-2-Carboxy-5-Methyl-2-(1-Methyl-1-Phenyl-Ethyl)-Cyclohexane Ester置于sodium Carbonate,双氧水,溶剂黄146体系中,用 二氯甲烷,水 用作溶剂,化学反应 10.0H,以85.6%的收率获得右旋酮洛芬
    参考文献:一种右旋酮洛芬中间体的合成方法
    标题:一种右旋酮洛芬中间体的合成方法
    摘要:本发明属于医药技术领域,具体涉及一种右旋酮洛芬中间体的合成方法,利用darzens反应的不对称合成制备右旋酮洛芬的中间体,该方法能够提高反应的选择性,降低原料的损耗,提高收率且简化操作流程,有利于实现工业化生产.

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-2012029226-A1
    优先权日:2009-02-06
    标题:Method for the synthesis of chiral alpha-aryl propionic acid derivatives
    发明人:KAPTEIN BERNARDUS; VLIEG ELIAS; NOORDUIN WILLEM LIEUWE
    权利人:KAPTEIN BERNARDUS; VLIEG ELIAS; NOORDUIN WILLEM LIEUWE
    摘要:The present invention provides a method for the synthesis of optically pure α-aryl propionic acid derivatives comprising subjecting the corresponding racemic α-aryl propionic acid derivatives to high sheer or impact forces, such as grinding.

    专利号:US-4097522-A
    优先权日:1975-06-05
    标 题:Synthesis of m-benzoyl-hydratropic acid
    发明人:BAIOCCHI LEANDRO
    权利人:ACRAF
    摘要:A process is provided for the production of m-benzoyl-hydratropic acid which comprises heating the reaction mixture obtained from the condensation of 2-benzoyl-cyclohexanone and pyruvic acid, its esters or salts, at a temperature of 200° to 230° and in the presence of an acid catalyst.

    专利号:US-2015352230-A1
    优先权日:2013-01-11
    标 题:Synthesis and isolation of dendrimer based imaging systems
    发明人:MULLEN DOUGLAS GURNETT; BAKER JR JAMES R; BANASZAK HOLL MARK M; HUANG BAOHUA; DOUGHERTY CASEY; BALL JACK
    权利人:UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis and isolation of antibodies conjugated with modular dendrimer nanoparticles. In particular, the present invention is directed to antibodies conjugated with novel modular dendrimer nanoparticles having precise numbers of imaging agents, methods of synthesizing the same, compositions comprising such antibodies conjugated with such modular dendrimer nanoparticles, as well as systems and methods utilizing the conjugates (e.g., in imaging settings) (e.g., in diagnostic and/or therapeutic settings) (e.g., for the delivery of therapeutics, imaging, and/or targeting agents).

    专利号:US-2012232225-A1
    优先权日:2009-08-26
    标 题:Synthesis and isolation of dendrimer systems
    发明人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL
    权利人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis and isolation of dendrimer systems. In particular, the present invention is directed to novel dendrimer conjugates with defined and limited numbers of ligand conjugates and high levels of structural uniformity, methods of synthesizing the same, compositions comprising the conjugates, as well systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer) diagnosis and/or therapy, pain therapy, etc.)).

    专利号:US-9402911-B2
    优先权日:2011-12-08
    标题:Multifunctional small molecules
    发明人:BAKER JR JAMES R; HUANG BAOHUA M; THOMAS THOMMEY P
    权利人:UNIV MICHIGAN REGENTS
    摘要:The present invention relates to dendrimer synthesis. Specifically, the present invention relates to dendrimer compositions (e.g., scaffolds) capable of copper-free click conjugation for use in the synthesis of functionalized dendrimers, and methods of use of the same.
    北大医药股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.pku-hc.com
    电话: 023-67502832👤
    📞北大医药股份有限公司 ⚠️参考联系方式

    销售电话:023-67502832
    邮箱:sspc@pku-hc.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Hanna M, Moon JY. A review of dexketoprofen trometamol in acute pain. Curr Med Res Opin. 2019 Feb;35(2):189-202. doi: 10.1080/03007995.2018.1457016. Epub 2018 Apr 24. 5(5):CD007355. doi: 10.1002/14651858.CD007355.pub3.
    3: Gay-Escoda C, Hanna M, Montero A, Dietrich T, Milleri S, Giergiel E, Zoltán TB, Varrassi G. Tramadol/dexketoprofen (TRAM/DKP) compared with tramadol/paracetamol in moderate to severe acute pain: results of a randomised, double-blind, placebo and active-controlled, parallel group trial in the impacted third molar extraction pain model (DAVID study). BMJ Open. 2019 Feb 19;9(2):e023715. doi: 10.1136/bmjopen-2018-023715. Erratum in: BMJ Open. 2019 Jun 14;9(6):e023715corr1.
    4: What place is there for tramadol/dexketoprofen? Drug Ther Bull. 2018 Jun;56(6):66-68. doi: 10.1136/dtb.2018.6.0635. 15(5):929-935. doi: 10.4103/1673-5374.268926.

    合成参考文献


    摘要:Mukherjee, S., Science of Synthesis: Asymmetric Organocatalysis, (2012) 1, 265.
    摘要:Bertau, M.; Jeromin, G. E., Science of Synthesis: Biocatalysis in Organic Synthesis, (2015) 1, 178.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知